Imagerie hybride TEMP/TDM de l’épiphysiolyse de hanche

Epiphysiolysis is a slipping of the superior femoral epiphysis under the effect of mechanical stresses. Rare event of end of growth, its incidence tends to increase with the increase of the overweight and the obesity in the child. The slipping can be progressive or acute and evolves spontaneously to fusion without pseudarthrosis or osteonecrosis but at the price of deformation and frequent secondary hip osteoarthritis. The treatment is surgical, with an iatrogenic risk of osteonecrosis if an osteotomy is performed. Although SPECT/CT bone scintigraphy has only a limited role at the initial stage (stage I), its major interest may be to evaluate the vitality of the capital femoral epiphysis, in particular a few weeks after surgery for epiphysiolysis with large displacement, before resuming hip support and/or in case of material MRI artifact resulting in an impossible assessment of vitality.     

Comparaison de l’IRM de diffusion et de la TEP/TDM au FDG dans le bilan des lymphomes

PurposeDiffusion weighted MRI (DW-MRI) sequences appear as a promising functional technique supplementary to morphologic MRI for oncology purposes. We evaluated the results of DW-MRI for the staging of lymphomas, compared to FDG PET/CT.MethodsTwenty-seven patients with lymphoma referred for FDG PET/CT (initial staging, relapse or treatment evaluation) were prospectively included. They underwent MRI including free breathing DW and T2 weighted imaging. Lymph node areas and organs involvement were listed for each modality and compared using Cohen's kappa (κ) test. MRI performances were evaluated using FDG PET as the gold standard. The results of PET and MRI were compared (with respect to the final staging by the haematologist).ResultsRegarding the lymph nodes, 154 involved areas were detected by MRI out of the 184 detected by PET, that is an excellent concordance (κ = 0.87), sensitivity of 0.84 and specificity of 1. Concordance and sensitivity were inferior for extranodal disease (notably bone lesions) with 27 lesions detected by MRI out of the 40 viewed with PET. Regarding pre-treatment evaluation, two patients were understaged both with PET and MRI (bone marrow involvement); assessment of stage was concordant for both modalities in 18 patients out of 21.ConclusionsPerformance of MRI including DW images was close to that of FDG PET/CT for lymph node areas involvement. Further studies are needed to assess its sensitivity for extranodal lesions, and its accuracy for determining the stage of the disease.     

Apport de la TEP/TDM au FDG en cancérologie de l’intestin grêle

This article focuses on the indication for FDG PET/CT in case of tumours of the small intestine, neuro-endocrine tumours excluded. The adenocarcinomas, lymphomas and sarcomas (including stromal tumours or GIST) are studied. There is no specific recommendation for FDG PET/CT in adenocarcinomas, extremely rare in comparison with colorectal adenocarcinomas. However, the utility of FDG PET/CT has been reported in clinical cases for detection and staging, especially in patients with high risk of developing the disease (Crohn's disease being the most important risk factor). The primary lymphomas of the small gut are also very rare, corresponding in all cases to non-Hodgkin lymphomas, for which the role of FDG PET/CT is recognised in follicular lymphoma, large B-cell lymphoma and Burkitt lymphoma. The stromal tumours correspond to the most frequent sarcomas. Stromal tumours in the small intestine are less frequent in the small intestine than in the stomach. The role of FDG PET/CT is well established in stromal tumours for the staging of the disease and for determining the efficacy of therapy with tyrosine kinase inhibitor. FDG PET is especially effective to evaluate the response since the radiologic criteria are difficult to assess, based not on the decrease of size of the lesions but on the decrease of density and of contrast enhance.     

TEMP/TDM et TEP/TDM en cardiologie : quel avenir ?

Over the recent years, clinical cardiology has witnessed a rapid evolution of multi-slice computed tomography (CT), starting with 4-slice CT developing into the current state of the heart 64-slice CT technology. This technology permits non-invasive visualization of the coronaries with high precision. CT coronary angiography will likely play an important role in the diagnosis of coronary artery disease. Because not all coronary stenoses detected by CT angiography are flow limiting, the stress myocardial perfusion imaging data complement the CT information. The integration of nuclear imaging (SPECT or PET) and CT data provides a potential opportunity to delineate the anatomic extent and the physiologic severity of coronary artery disease. The objective of this article is to provide a critical view of the relative strengths and weaknesses of myocardial perfusion imaging and CT coronary angiography, which we hope will help elucidate the potential role of these modalities in the diagnosis and management algorithms of patients with known or suspected coronary artery disease.     

Place de la scintigraphie osseuse planaire et TEMP/TDM dans l’exploration des prothèses de hanche douloureuses

Investigation of hip pain in a patient bearing a hip prosthesis is a common indication in Nuclear Medicine departments daily practice. Indeed, morphological cross-sectional imaging devices, such as MDCT and MRI, are often hampered by metallic implants. If planar bone scintigraphy is acknowledged with a high sensitivity, nonetheless, this exam specificity is poor. Since Anger cameras twinned with spiral CT (SPECT/CT) have appeared in the clinical arena, this limited specificity is compensated by the CT threefold input, all at once attenuation correction, localizing and diagnostic tool. Bone SPECT/CT requires that the Nuclear Medicine physician upgrades his knowledge of bone and joint anatomy, CT patterns, but foremost, data merging from SPECT and CT. The aim of this article is to sketch out bone SPECT/CT role and patterning in miscellaneous complications following arthroplasty, explained by pathophysiological mechanisms.     

Comparaison IRM de diffusion corps entier et TEP/TDM au 18FDG dans le diagnostic de myélome symptomatique

IntroductionOur work aims to compare whole-body diffusion MRI (DWMRI) and ¹⁸FDG PET/CT in the diagnosis of symptomatic myeloma.Patients and methodFrom November 2008 till May 2010, 19 patients were investigated by DWMRI and by ¹⁸FDG PET/CT. The patients were classified according to the criteria of the International Myeloma Working Group in eight non-symptomatic myelomas and 11 symptomatic myelomas. The sensitivity and the specificity of two methods of imaging were studied by retaining the presence or the absence of a diffuse infiltration (ID), focal lesions (FL), or both parameters (FL + ID), in both modalities of imaging. We compared the concordance between two techniques for every patient by using these signs using a weighted kappa test.ResultsThe performances of both modalities seem comparable, with superior diagnostic performances for the FL (Se = 100% and Sp = 75% in DWMRI and Se = 91% and Sp = 75% for ¹⁸FDG PET/CT). By combining both parameters, the ¹⁸FDG PET/CT seems more specific, but the sensitivity is comparable in both modalities (Se = 100% in MRI and Se = 100% in ¹⁸FDG PET/CT; Sp = 37% in DWMRI and Sp = 62% for ¹⁸FDG PET/CT). The concordance between both techniques is better by taking into account the FL than the other parameters (weighted kappa = 0.61 for FL, 0.5 for the FL + ID and 0.16 for ID alone).ConclusionDiagnostic performances of whole-body diffusion MRI and ¹⁸FDG PET/CT seem equivalent, but concordance between both techniques is imperfect. Further studies are necessary to understand this discrepancy.     

Évaluation de l’irradiation additionnelle des patients de médecine nucléaire en imagerie hybride TEMP/TDM

One hundred and ten consecutive patients and 130 SPECT/CT examinations were involved in this retrospective study that focused on the evaluation of the excess of dose contributed by the CT to the patient during the SPECT/CT explorations, for routine examinations in nuclear medicine. The average age of patients was 53 years. In this study, it appeared that irradiation induced by a low dose CT combined with a SPECT is low compared to that of a diagnostic CT. The main risk on patients is the occurrence of radiation-induced cancer. In our study, this increased risk induced by the additional CT with low dose settings in line with SPECT examination, is not significant and does not exceed 0.026%. By weighing the diagnostic value of SPECT/CT examination with that of a stand-alone SPECT examination dosimetric “incremental cost” is justified because of its direct clinical benefit conveyed to the patient.     

TEP/TDM au fluorure (18F) de sodium pour la détection des métastases osseuses du cancer de la prostate. Description de l’étude Fluprostic de comparaison de la TEP/TDM au fluorure (18F) de sodium à l’IRM corps entier dans cette indication

Fluorodeoxyglucose (¹⁸F) or FDG, the radioactive glucose analogue which is the reference radiopharmaceutical in oncologic PET, is not well suited for the detection of prostate cancer metastases the glucose metabolism of which is usually only slightly enhanced. Fluoride (¹⁸F) accumulates into the cortical bone, rapidly and intensely in reaction to a bony metastasis. In 2008, it has been granted a marketing authorisation in France, including imaging bone metastasis of prostate cancer. We report original clinical cases to illustrate its diagnostic performance. Whole-body MRI is developing and can also detect bone metastases. Recently diffusion-weighted MRI (DWI) has been proposed to increase the detection rate of metastases of the axial skeleton, which are largely predominant in prostate cancer. Using either hybrid PET/CT or MRI requires mobilising equipments, which are less available and more expensive than the gamma-cameras for classical bone scintigraphy, in the aim to achieve superior diagnostic performance. A clinical study protocol (STIC) has just been accepted for public funding. It aims to assess the impact on patient management of the discovery of the first macroscopic bony metastasis and the efficacy of diagnostic strategies including those innovations, individually and in association. In case of prostate cancer with a high risk of metastasis, but without any proven bone metastasis and no typical pattern on bone scintigraphy, fluoride (¹⁸F) PET/CT will be performed as well as whole-body MRI. Histopathology and/or data of a 6-month follow-up will be the standard of truth to evaluate the adequacy of impact on patient management and the benefit / cost ratio of those examinations. With this prospective national study, we hope to demonstrate in the real world a clinical role for this radiopharmaceutical, which was proposed several decades ago, but benefits from a renewed interest thanks to the development of PET/CT imaging.     

L’apport de l’imagerie hybride TEMP/TDM dans la prise en charge du cancer différencié de la thyroïde

IntroductionSingle photon emission computed tomography combined with a low dose computed tomography (SPECT/CT), is a hybrid imaging integrating functional and anatomical data. The purpose of our study was to evaluate the contribution of the SPECT/CT over traditional planar imaging of patients with differentiated thyroid carcinoma (DTC).MethodsPost-therapy iodine 131 (¹³¹I) whole-body scan followed by cervico-thoracic SPECT/CT, were performed in 100 patients with DTC.ResultsAmong these 100 patients followed for a predominantly papillary DTC, planar imaging and SPECT/CT, were perfectly concordant in 70% of patients and discordant in the remaining 30%. The use of fusion imaging SPECT/CT compared to conventional planar imaging allowed us to correct our therapeutic approach in 27% (27/100 patients), according to the protocols of therapeutic management of our institute.ConclusionSPECT/CT is a hybrid imaging modality which provides better identification and more correct anatomic localization of the foci of radioiodine uptake with impact on therapeutic management.     

Impact de l’imagerie hybride TEMP/TDM dans le diagnostic et la prise en charge de l’ostéome ostéoïde

IntroductionThe osteoid osteoma is a major bone benign tumors in children. It is more common in boys. The femoral and tibial locations account for 50% of cases. Clinically, it is revealed by nocturnal pain relieved by aspirin. The pain may precede by several months the radiographic abnormality. The purpose of our work is to elucidate the contribution of SPECT/CT in addition to the planar bone scintigraphy in the diagnosis and treatment of osteoid osteoma about two cases.Case reportClinical case No. 1: a 10-year-old child who presented a limp nocturnal pain in the left hip evolving for 4 months. The radiograph of the pelvis showed bone condensation subtrochanteric left femur. SPECT/CT showed an image for an osteoid osteoma. Surgical resection of the home revealed in the histological study an osteoid osteoma of the left femoral neck. The evolution was marked by an immediate pain relief and full recovery of the left lower limb mobility. Clinical case No. 2: an 11-year-old child who had a limp nocturnal pain at the upper end of the left femur evolving for 2 months. The pain was paroxysmal, relieved by salicylates. The X-ray of the pelvis showed a metaphyseal image with peripheral condensation and thickening of the cortex. SPECT/CT showed an image for an osteoid osteoma. The intervention was a tumor excision resection. Histopathological examination revealed a small nidus consistent with an osteoid osteoma. The evolution was marked by an immediate pain relief and normalization of the mobility of the left lower limb.DiscussionThe SPECT/CT can increase the sensitivity and specificity of planar bone scintigraphy. It confirms the location of osteoid osteoma and defines its anatomical relationships in order to optimize surgical management.ConclusionThe SPECT/CT contributes significantly to the diagnosis of osteoid osteoma when radiological images are atypical or unusual clinical expression.     

Forme pseudo-tuberculeuse d’un carcinome épidermoïde du poumon exploré par TEP/TDM

In Oncology, PET/CT images interpretation can prove tricky due to the lack of specific radiolabelled tracers. We present a tobacco addict 58 years old man with lung squamous cell carcinoma mimicking evolutive tuberculosis on radiological imaging. In this patient, a negative sputum analysis of mycobaterium tuberculosis and scanty radiologic data triggered a PET/CT exam. Eventually, biopsy conveyed the proper diagnosis of lung squamous cell carcinoma. Ordering a PET/CT examen must take into account good analysis of radiologic imaging and endoscopic data susceptible to bring essential information in lung tumours related clinical conditions; allowing to streamline the diagnostic work-up.     

Apport de la TEP/TDM dans les cancers broncho-pulmonaires : étude d’une série de 35 cas

Lung cancer is one of the most common cancers in Morocco. Currently, PET/CT with FDG is described as the best suited imaging test to evaluate the initial extension of this type of cancer in it non-metastatic variety. Our study confirms the literature data, showing the superiority of PET/CT versus CT in the initial staging of lung non-small cell carcinoma.     

Impact de la TEP/TDM au 18F-FDG dans la prise en charge des patients atteints de cancer thyroïdien différencié

Aim¹⁸F-FDG PET/CT by combining both metabolic and anatomical informations has proven to be an effective modality for detecting many types of cancer. Some differentiated forms of cancer like differentiated thyroid carcinoma (DTC) are less FDG avid and thus less easily detectable. Nevertheless ¹⁸F-FDG PET/CT has been proved useful in DTC especially in case of suspected recurrent disease with negative whole-body radioiodine scintigraphy (¹³¹I WBS) and elevated thyroglobulin (Tg) or thyroglobulin autoantibodies (AbTg) levels. Impact on clinical management after ¹⁸F-FDG PET/CT examinations has been analyzed in patients with suspected recurrent DTC in this retrospective study.MethodologyFifty-five ¹⁸F-FDG PET/CT were performed in 45 patients with suspected recurrent or residual disease either because of elevated Tg/AbTg levels (n = 45) or uncertain conventional imaging (n = 10) including ¹³¹I WBS, cervical echography and CT scan if necessary. ¹⁸F-FDG PET/CT results were compared with histopatology and/or clinical follow-up with evaluation of impact on clinical management.ResultsTwenty-nine exams were positive (53 %). There were 20 true-positive (TP) (14 locoregional relapses and six with distant metastases) and nine false-positive (FP) (all cervical). SUV_max median values of hypermetabolic foci were significantly higher in TP (5.1) than in FP (2.8). Overall, 20 (36 %) ¹⁸F-FDG PET/CT directly affected clinical management resulting in 13 (65 %) new surgical operations. Sensitivity, specificity, predictive positive value, predictive negative value and accuracy of ¹⁸F-FDG PET/CT were estimated for the whole group (respectively 83 %, 71 %, 69 %, 85 % and 76 %) and for two subgroups depending on Tg level (less or more than 1.2 ng/mL).Discussion and conclusion¹⁸F-FDG PET/CT is a powerful and useful tool in patients with suspected DTC recurrence or residual disease and should be systematically performed when basal Tg level is above 1.2 ng/mL. Thanks to given anatomical informations it can guide surgical re-operation.     

Impact diagnostique de la TEMP–TDM dans l’exploration des tumeurs endocrines

Image fusion using single photon emission computed tomography–computed tomography (SPECT–CT) associates functional and morphological images. This study evaluates the added value of SPECT–CT, obtained with a hybrid SPECT–CT gamma camera, on anatomic localization and diagnostic impact in assessment of endocrine tumours and pheochromocytomas.MethodSix months prospective study was undertaken including 33 consecutive exams encompassing 20 Somatostatin Receptor Scintigraphies (SRS) and 13 ¹²³I-meta-iodo-benzyl-guanidine (MIBG) scans. Two experienced nuclear medicine physicians independently analysed independently planar and SPECT images in a first time, then, SPECT–CT fused images in a second time. They evaluated two parameters: SPECT–CT impact on anatomic localization (LA) and its diagnostic impact (ID). Each parameter was scored according three levels of evaluation.ResultsAn added value of SPECT–CT images was evidenced in 55% of cases on the anatomic localization and in 41% of the patients on the diagnostic impact. Therefore, a more important benefit was noted when SPECT was positive (LA: 90%; ID: 70%) than when it was negative (LA: 15%; ID: 8%). Furthermore, the added value proved higher for the SRS compared to MIBG scans.ConclusionSPECT–CT fusion images obtained by a hybrid system is more relevant to determine anatomic localization and more accurate than SPECT alone, particularly in the assessment of endocrine tumours. The added value of SPECT–CT seems to be lower for MIBG scans in the assessment of pheochromocytomas.     

Évaluation de la place de la TEMP/TDM du squelette axial dans le diagnostic des métastases osseuses : étude prospective à propos de 150 cas

Aim of the study

Show the added value of SPECT-CT of the trunk in the diagnosis of bone metastases, compare its results to those of whole body scintigraphy (WBS) and specify the diagnostic impact while taking into account the cost of additional irradiation attributable to the scanner.

Taux de fixation de la pointe du ventricule gauche et correction d’atténuation TEMP/TDM dans la scintigraphie myocardique de perfusion chez les patients non ischémiques

Introduction

Attenuation correction (AC) has been shown to improve the accuracy of myocardial perfusion single photon emission computed scintigraphy (SPECT). It often reveals a decrease in apical uptake in the AC of the left ventricular (LV) in non-ischemic patients. We aimed to identify the parameters that could affect the apical radiotracer uptake in non-ischemic patients.

Comparaison des performances de deux systèmes TEP/TDM corps entier selon la norme NEMA NU 2-2001

The goal of work is the characterization of two PET/CT units that are based on different technologies, using the methodology proposed in the NEMA NU 2-2001 standard. The two systems were qualified in the 3D acquisition mode by means of the National Electric Manufacturers Association (NEMA) phantoms. The results obtained showed that the NEMA standard allows to highlight differences in terms of spatial resolution, sensitivity, scatter fraction and counting rate performances between the two systems ; differences that can be explained by the geometry of the units and the materials of the detectors used. Thus, the use of the standard makes it possible to benchmark PET units and establish reference values that can be used to follow the stability of the system over the time. The tests of image quality, obtained under conditions closer to the clinical applications, showed nevertheless that the two units give, in spite of different technologies, images with sufficient contrast, within short acquisition times, allowing the detection of small lesions. This test should be part of the constancy tests to enable the comparison of examinations performed on different units when the quantitative aspects are of importance.     

Valeur pronostique de la TEP/TDM dans le bilan initial du cancer du col utérin : SUVmax de la tumeur primitive et stadification ganglionnaire

PurposeWe investigated the prognostic significance of F-18 fluorodeoxyglucose (FDG) uptake measured as maximum Standardized Uptake Value (SUV_max) in primary tumor by positron emission tomography/computed tomography (PET/CT) in cervical cancer. The secondary objective was to determine the accuracy of the PET/CT for detecting pelvic lymph node (PLN) and para-aortic lymph node (PALN) metastases.MethodsThis retrospective study included 49 consecutive patients with stage IB1 to IVB cervical cancer. Univariate analysis was performed to determine the relationships between SUV_max value and pathological prognostics factors. Survival was estimated by Kaplan-Meier method. The gold standard of LN metastases was histologic.ResultsA significant difference in SUV_max was observed between stage I and stage II, stage I and stage IV and tumor size ≤ 4 cm and > 4 cm (P = 0.0001). There was a significant correlation between the SUV_max and tumor maximal size (r = 0.597) (P < 0.0001). PLN metastasis was found to be predictive of progression-free survival (P = 0.0007). The negative predictive value (NPV) of the PET/CT for PALN was 100% for locally advanced cervical carcinoma in 24 patients. The specificity and NPV of the PET/CT for PLN in eight early-stage cervical cancer were 100% and 87.5% (7/8) respectively. The PET/CT false-negative PLN measured less than 2 mm.ConclusionOur results demonstrate a correlation between SUV_max and tumor maximal size, which represents an indicator of tumor aggressiveness. PET/CT is effective to predict the absence of PALN in locally advanced cervical carcinoma. PET/CT is not sufficient to predict PLN in early-stage cancer without lymphadenectomy.